Instant coffee and powdered milk are produced by spray drying. Fraunhofer researchers have adapted this technique to the tricky question of incorporating insoluble substances in core-shell particles. The new method helps reduce the concentration of active ingredients in therapeutic medications.
Encapsulation is used in cosmetics and pharmaceuticals to protect active ingredients against external influences such as aggressive gastric acid. Another use of encapsulation is to control the release of active ingredients inside the body: depending on the permeability of the shell material, the medication is delivered gradually rather than all at once. Because such systems release multiple, smaller doses over an extended period of time, the drug therapy is better tolerated and easier to administer. In some cases, it means taking just one pill a day instead of three.
Insoluble substances are a problem
The first step of the encapsulation process involves dissolving the active ingredient in a liquid medium and mixing it with the shell material. Then the solution is piped to an orifice in the center of a nozzle surrounded by an annular channel through which compressed air is injected at high speed. The pressure disperses the solution into an aerosol of fine droplets, which is then sprayed into a drying cylinder. Here, the liquid evaporates, leaving behind a fine powder of core-shell particles. The problem is that it is difficult to mix insoluble substances with other materials. This limits the choice of shell materials that can be used to produce the particles.
Three-way nozzle permits endless combinations of materials
“For this reason, we use a three-way nozzle to implement spraying. Its advantage is that it permits two substances to be fed separately to the nozzle. The shear forces mix the substances together at the orifice of the nozzle, creating an aerosol containing both materials,” explains Michael Walz, who developed and optimized the new technique with his colleague Dr. Achim Weber at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart.
This system permits endless combinations of materials, enabling the controlled release of active ingredients to be adapted to different applications. “We can modify the particle size and encapsulation efficiency by selecting the appropriate substances and by varying the concentration of the solution, the liquid volume flow, the drying temperature, and the pressure applied to the nozzle. This gives us the capability to respond to almost any customer requirement and develop solutions tailored to their needs,” says Weber.
The new process for the encapsulation of active ingredients could be of interest to fertilizer manufacturers and food processing companies as well as the cosmetics and pharmaceutical industries.
The Latest on: Drug delivery
- Lexaria Bioscience Corp. is Changing the Future of Drug Deliveryon March 2, 2021 at 6:44 pm
Lexaria Bioscience Corp. (NASDAQ: LEXX) is developing emerging technology that promotes faster delivery of drugs into the bloodstream, among other patented innovative health initiatives, making the ...
- Youngwood man to remain in jail to await drug delivery resulting in death trialon March 2, 2021 at 5:20 pm
A Youngwood man will remain in jail to await trial on a charge that he delivered drugs to a woman who died from an overdose in August 2019. Matthew Thomas Caughey pleaded for his release during a ...
- Computational modelling of nanotube delivery of anti-cancer drug into glutathione reductase enzymeon March 2, 2021 at 8:48 am
Density functional theory method combined with docking and molecular dynamics simulations are used to understand the interaction of carmustine with human glutathione reductase enzyme. The active site ...
- ScPharmaceuticals plots refiling of twice-rejected on-body drug delivery producton March 2, 2021 at 7:34 am
The company expects to be ready to refile once it has completed work including modified bench tests on aged commercial units of its on-body drug delivery system. Furoscix is designed to give patients ...
- Liposome Drug Delivery Market Growth Analysis By Revenue, Size, Share, Scenario on Latest Trends & Types, Applications to Forecaston March 1, 2021 at 10:18 pm
Global Size, Share, Trends, Forecast, Growth, Key Players & Regional Analysis (Latin America, North America, Asia Pacific, Europe, Middle East) "The report on Liposome Drug Delivery Market was ...
- Global Connected Drug Delivery Devices (Bluetooth, NFC, Other) Market Size, Share & Trends Analysis Report 2021-2028 - ResearchAndMarkets.comon March 1, 2021 at 9:35 pm
ResearchAndMarkets.com The “Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report by Technology (Bluetooth, NFC), by Product (Connected Sensors, Integrated Connected Devices), by ...
- Pharmaceutical Drug Delivery Market 2021 Set for Rapid Growth and Trend by 2021-2026 with Top Countries Dataon February 28, 2021 at 7:31 pm
According to 360 Research Reports, the “ Pharmaceutical Drug Delivery Market " 2021 by Types (Oral, Pulmonary, Injectable, Topical, Other), Application (Cancer, Diabetes, Other) and Region - Global ...
- Beam Therapeutics Adds To Drug Delivery With $120M GuideTx Buyon February 23, 2021 at 5:47 pm
Beam Therapeutics Inc (NASDAQ: BEAM) acquires Guide Therapeutics (GuideTx), a developer of nonviral drug delivery vehicles for genetic medicines, in an all-stock deal for $120 million upfront. GuideTx ...
- Beam Therapeutics acquires a biotech focused on drug deliveryon February 23, 2021 at 2:53 pm
The Cambridge-based gene editing company is acquiring Georgia Tech spinout Guide Therapeutics for $120 million upfront.
- Enhancing Drug Delivery Systems With Lexaria's Technologyon February 17, 2021 at 6:19 am
Lexaria Bioscience was one of the Benzinga Global Small-Cap Conference sponsors on December 8-9, 2020. The information contained in this article in no way represents investment advice or opinion on ...
via Google News and Bing News